日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and predictors of virological non-suppression in Thailand's rollout of dolutegravir-based first-line antiretroviral therapy: A nationwide cohort analysis

泰国推广以多替拉韦为基础的一线抗逆转录病毒疗法的疗效及病毒学抑制失败的预测因素:一项全国性队列分析

Hiranburana, Napon; Sophonphan, Jiratchaya; Kerr, Stephen J; Lertpiriyasuwat, Cheewanan; Noknoy, Sairat; Jirajariyavej, Supunnee; Fujitnirun, Chris; Chetchotisakd, Ploenchan; Lolekha, Rangsima; Bowonwatanuwong, Chureeratana; Ruxrungtham, Kiat; Putcharoen, Opass; Avihingsanon, Anchalee

Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy

在泰国结核病/艾滋病高负担地区,接受长期抗逆转录病毒治疗的艾滋病毒感染者中活动性结核病的发生率:对结核病预防治疗的启示

Suwanpimolkul, Gompol; Gatechompol, Sivaporn; Kawkitinarong, Kamon; Ueaphongsukkit, Thornthun; Sophonphan, Jiratchaya; Siriyakorn, Nirada; Jirajariyavej, Supunnee; Khusuwan, Suwimon; Panarat, Palakorn; Wannalerdsakun, Surat; Saetiew, Natcha; Chayangsu, Sunee; Wiwatrojanagul, Sirichai; Noopetch, Preudtipong; Danpornprasert, Praniti; Mekviwattanawong, Sripetcharat; Fujitnirun, Chris; Lertpiriyasuwat, Cheewanan; Han, Win Min; Kerr, Stephen J; Ruxrungtham, Kiat; Avihingsanon, Anchalee